Polymer Nanoparticle-Based Controlled Pulmonary Drug Delivery

The development of novel formulations for controlled pulmonary drug delivery purposes has gained remarkable interest in medicine. Although nanomedicine represents attractive concepts for the treatment of numerous systemic diseases, scant information is available on the controlled drug release characteristics of colloidal formulations following lung administration, which might be attributed to the lack of methods to follow their absorption and distribution behavior in the pulmonary environment.
Source: Springer protocols feed by Biotechnology - Category: Biotechnology Source Type: news